About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,504 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,504 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5221-5240 of 7,504 trials

UnknownStudy Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerThis Phase I/Ib study is a Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of GZ17-6.02 Monotherapy and in Combination with…NCT03775525·Scottsdale, Arizona and 3 others UnknownNanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)There is a growing body of evidence exploring the role of curcumin as a radioprotector against radiation-induced injury in normal tissues as well as a radiosensitizer in tumor…NCT02724618·Tehran Active not recruitingMRI for Assessment of Hypoxia-Induced Prostate Cancer AggressivenessThe purpose of the study is to combine and correlate data from morphological and functional MRI, molecular signatures of tumor hypoxia, the presence of micrometastases and tumor…NCT01464216·Oslo CompletedPreoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRIProstate cancer (PCa) is currently the most common neoplastic disease among men in well-developed countries with 350 000 new cases diagnosed annually in Europe and 4 800 in…NCT02002455·Turku

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedHypofractionated Radiotherapy for Prostate CancerRadiotherapy is a standard definitive treatment for men with localized prostate cancer.NCT03851926·Terrassa, Barcelona

CompletedAcceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersThis pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners.NCT03112668·New Brunswick, New Jersey

CompletedCharacterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)This pilot study will aim to determine whether circulating tumor cells (CTCs) can be captured using the novel cMET based ferrofluid.NCT02080650·Durham, North Carolina

UnknownPredictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck CancerThe main idea behind MICRO-LEARNER is to provide new insights about the response of healthy tissues to radiation by using information from the micro-environment obtained by…NCT03294122·Milan

CompletedActive Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer STARTThe purpose of the START project is to evaluate the acceptability, the safety and the cost-effectiveness of a population based program of active surveillance for patients newly…NCT03348722·Turin

RecruitingStudy of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)The purpose of this study is to assess the safety, tolerability and preliminary efficacy of HRS-5041 in men with progressive metastatic castration resistant prostate cancer.NCT05942001·Shanghai, Shanghai Municipality

UnknownMR-targeted vs. Random TRUS-guided Prostate BiopsyTo compare prostate cancer (PCa) detection rate of magnetic resonance (MR)-targeted biopsy and transrectal ultrasound (TRUS)-guided biopsy in patients with high PSA values and at…NCT02678481·Candiolo, Turin

CompletedEvaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate CancerWith functional imaging development, it becomes possible to increase radiation dose to radioresistant areas (located inside tumor volume) using radiotherapy dose-painting.NCT01898065·Poitiers and 1 other

TerminatedContrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)Solid tumors, including prostate cancer, commonly exhibit tumor-associated neovascularity (growth of new blood vessels to feed the tumor) with increased microvessel density.NCT00635167·Philadelphia, Pennsylvania

RecruitingA Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.Prostate cancer (PCa) management for low- and intermediate-risk patients often involves radical prostatectomy (RP), which achieves oncologic control but is associated with…NCT07348367·Detroit, Michigan

WithdrawnRadiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the ProstateThe purpose of the study is to assess the safety of four different doses of radiation therapy followed by to surgery to remove prostate tumor.NCT00691977·Richmond, Virginia

TerminatedDocetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate CancerThe purpose of this study is to find out what effects, good and bad, the combination of docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer…NCT00577356·Seattle, Washington

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

CompletedExercise Training as a Novel Primary Therapy for Men With Localised Prostate CancerStudy design: The study is a two arm randomised controlled trial (randomisation ratio 1:1) comparing an aerobic exercise training intervention to usual care plus exercise advice.NCT02409212·Sheffield, South Yorkshire

CompletedChanges in DNA After Radiation Therapy in Patients With Prostate CancerRATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA after…NCT00899912·Atlanta, Georgia and 9 others

RecruitingStandard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)PEACE-6 Poor Responders is an international, multicenter, open-label, controlled, randomized, phase III trial to evaluate the efficacy and safety of 177Lu-PSMA-617 when…NCT06496581·Angers and 24 others

PreviousPage 262 of 376Next